All Title Author
Keywords Abstract

New Advances in Juvenile Idiopathic Arthritis

Keywords: juvenile idiopathic arthritis , etiology , biologic agents

Full-Text   Cite this paper   Add to My Lib


Juvenile idiopathic arthritis (JIA) comprises a group ofheterogeneous disorders of chronic arthritis in childhood withno apparent etiology. Juvenile idiopathic arthritis is the mostcommon pediatric rheumatic disease and is associated withsignificant long-term morbidity and mortality. There have beenmajor advances in recent years in our understanding of thepathogenesis of JIA, the definition of disease control, and biological treatments for JIA. Multiple environmental and geneticfactors have been linked with the onset and / or the exacerbation of JIA, including perinatal factors, viral and bacterialinfections, epigenetic factors, and malnutrition. However, nosingle causative factor has been identified to date. As ourunderstanding of the complex network of immune cells andinflammatory cytokines has improved, biologics have beendeveloped to modulate the inflammatory processes. Indeed, anumber of such biologics have been demonstrated effective for the treatment of JIA.Although biologic agents may alleviate the inflammation associated with JIA and preventdisability caused by joint destruction, continued and comprehensive observation is requiredto determine the long-term outcomes associated with such treatment


comments powered by Disqus